Immunotherapy: A triple blow for cancer

Nature Reviews Cancer

Volumn 15, Issue 5, 2015, Pages 258-259

  Leavy, Olive ^a  

^a Nature Reviews Immunology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR;

CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CD8+ T LYMPHOCYTE; CELL COUNT; CELL POPULATION; CLINICAL TRIAL (TOPIC); HUMAN; MELANOMA CELL; METASTATIC MELANOMA; NONHUMAN; NOTE; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CYCLE CHECKPOINT; DRUG EFFECTS; FEMALE; IMMUNOLOGY; MELANOMA; RADIATION RESPONSE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD274; CELL CYCLE CHECKPOINTS; CTLA-4 ANTIGEN; FEMALE; HUMANS; MELANOMA; T-LYMPHOCYTES;

EID: 84928586985     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3946     Document Type: Note

References (1)

1. Twyman-Saint Victor, C. et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature http://dx.doi.org/10.1038/nature14292 (2015)